The report provides a detailed analysis essential for establishing a Dicoumarol production plant. It encompasses all critical aspects necessary for Dicoumarol production, including the cost of Dicoumarol production, Dicoumarol plant cost, Dicoumarol production costs, and the overall Dicoumarol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dicoumarol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dicoumarol is an organic chemical compound that is mainly used in the medical and research fields due to its anticoagulant properties. It is primarily used as a blood-thinning agent, where it helps prevent the formation of harmful blood clots by interfering with vitamin K activity in the body. It is mainly utilised in the treatment and study of thrombotic disorders, including conditions related to abnormal clotting.
It is also used in the treatment of conditions such as deep vein thrombosis, pulmonary embolism, and other clot-related disorders. It works by interfering with the synthesis of vitamin K-dependent clotting factors in the liver, thereby slowing down the blood clotting process. In addition, it plays an important role in pharmaceutical research as a reference compound for developing and evaluating newer anticoagulant drugs.
The market for Dicoumarol is mainly led by its usage as an oral anticoagulant agent to prevent and treat thromboembolic disorders, which boosts its demand in the medical sector. Its application as a drug in the treatment of deep vein thrombosis (DVT), pulmonary embolism, and thromboembolic complications from atrial fibrillation also promotes its demand in the pharmaceutical industry. Its usage in clinical research and laboratory studies to better understand blood coagulation mechanisms and the action of vitamin K antagonists also contributes to its demand in the medical research industry.
Factors including the availability and quality of starting materials, adherence to pharmaceutical regulations, and strict safety and handling requirements influence industrial Dicoumarol procurement. In addition, production consistency, supplier credibility, regulatory approvals, and efficient distribution systems play an important role in shaping global procurement trends for Dicoumarol.
Raw Material for Dicoumarol Production
According to the Dicoumarol production plant project report, the major raw materials for Dicoumarol production include 4-hydroxycoumarin and Formaldehyde.
Production Process of Dicoumarol
The extensive Dicoumarol production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Dicoumarol begins with the preparation of 4-hydroxycoumarin as the main intermediate. 4-hydroxycoumarin is made by converting methyl salicylate (salicylic acid methyl ester) into a chromone-type intermediate through a base-promoted cyclisation (using sodium or sodium methoxide). It can also be produced by reacting o-hydroxyacetophenone with diethyl carbonate in the presence of sodium ethoxide, which also forms the same 4-hydroxycoumarin scaffold. Once 4-hydroxycoumarin is obtained, it is then condensed with formaldehyde in a phenolic coupling reaction, which links two 4-hydroxycoumarin units through a methylene bridge to give dicoumarol (3,3′-methylene-bis(4-hydroxycoumarin)). Further, the resulting product undergoes routine purification steps to obtain pure Dicoumarol as the final product.
Dicoumarol is a naturally occurring anticoagulant agent that functions as a competitive inhibitor of vitamin K epoxide reductase and acts as a vitamin K antagonist. It appears as a white to off-white crystalline powder that is odourless and solid at room temperature. The molecular formula of the compound is C19H12O6, and its molecular mass is 336.29 g/mol. Its density is approximately 1.57 g/cm³, and it has a melting point ranging from 287 to 293 degree Celsius. The boiling point is approximately 620.7 degree Celsius at 760 mmHg, though the compound generally decomposes before reaching this temperature. It is almost insoluble in water, ethanol, and diethyl ether, slightly soluble in chloroform and benzene, but readily soluble in aqueous alkaline solutions, organic bases, and pyridine. The compound exhibits blue or purple fluorescence under ultraviolet light. Common side effects include gastrointestinal discomfort, bleeding complications, and potential drug interactions with various medications. It is contraindicated in patients with active bleeding disorders, severe liver disease, pregnancy, or known hypersensitivity to the compound.